Cargando…

Repurposing verapamil for prevention of cognitive decline in sporadic Alzheimer's disease

Detalles Bibliográficos
Autores principales:	Ahmed, Heba A., Ishrat, Tauheed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552840/ https://www.ncbi.nlm.nih.gov/pubmed/34558527 http://dx.doi.org/10.4103/1673-5374.324843

Ejemplares similares

Verapamil, a possible repurposed therapeutic candidate for stroke under hyperglycemia
por: Ismael, Saifudeen, et al.
Publicado: (2022)

Candesartan Effectively Preserves Cognition in Senescence Accelerated Mouse Prone 8 (SAMP8) mice
por: Ahmed, Heba A., et al.
Publicado: (2022)

Intra-arterial verapamil improves functional outcomes of thrombectomy in a preclinical model of extended hyperglycemic stroke
por: Nasoohi, Sanaz, et al.
Publicado: (2023)

Verapamil and vasospastic angina: underuse in the elderly population
por: Humbert, Xavier, et al.
Publicado: (2017)

Consequences of redefining Alzheimer's disease in terms of amyloid burden without regard to cognitive decline
por: Robinson, Stephen R., et al.
Publicado: (2018)

Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study
por: Desai, Rishi J., et al.
Publicado: (2020)

Repurposing ibrutinib: therapeutic effects and implications for translational approaches in Alzheimer’s disease
por: Lee, Hyun-ju, et al.
Publicado: (2023)

Primary prevention recommendations to reduce the risk of cognitive decline
por: Sabbagh, Marwan N., et al.
Publicado: (2022)

Principles of Design of Clinical Trials for Prevention and Treatment of Alzheimer’s Disease and Aging-Associated Cognitive Decline in the ACH2.0 Perspective: Potential Outcomes, Challenges, and Solutions
por: Volloch, Vladimir, et al.
Publicado: (2023)

Verapamil and Alzheimer’s Disease: Past, Present, and Future
por: Popović, Natalija, et al.
Publicado: (2020)

The Amyloid Cascade Hypothesis 2.0 for Alzheimer’s Disease and Aging-Associated Cognitive Decline: From Molecular Basis to Effective Therapy
por: Volloch, Vladimir, et al.
Publicado: (2023)

A vaccine to prevent initial loss of cognition and eventual Alzheimer's disease in elderly persons
por: Fessel, Jeffrey
Publicado: (2021)

Repurposing Verapamil to Enhance Killing of T-ALL Cells by the mTOR Inhibitor Everolimus
por: Silic-Benussi, Micol, et al.
Publicado: (2023)

Preventative medicine and Alzheimer’s disease: is Alzheimer’s disease risk reduction achievable?
por: Sinyor, Benjamin, et al.
Publicado: (2021)

The potential for one drug, administered at the earliest preclinical stage, to prevent the subsequent decline of cognition that eventuates in dementia
por: Fessel, Jeffrey
Publicado: (2020)

Cognitive decline assessment in speakers of understudied languages
por: Hatahet, Oula, et al.
Publicado: (2023)

Prevention of Alzheimer's disease by treating mild cognitive impairment with combinations chosen from eight available drugs
por: Fessel, Jeffrey
Publicado: (2019)

The pathway to secondary prevention of Alzheimer's disease
por: McDade, Eric, et al.
Publicado: (2020)

Antifungal Drug Repurposing
por: Kim, Jong H., et al.
Publicado: (2020)

Measuring cognition and function in the preclinical stage of Alzheimer's disease
por: Weintraub, Sandra, et al.
Publicado: (2018)

RAS modulation prevents progressive cognitive impairment after experimental stroke: a randomized, blinded preclinical trial
por: Ahmed, Heba A., et al.
Publicado: (2018)

Prevention of Cognitive Decline in Alzheimer’s Disease by Novel Antioxidative Supplements
por: Tadokoro, Koh, et al.
Publicado: (2020)

Can we treat neurodegenerative diseases by preventing an age-related decline in microRNA expression?
por: Vinnikov, Ilya A., et al.
Publicado: (2017)

Finding effective combinations of compounds to prevent Alzheimer’s disease
por: Dhakal, Sudip, et al.
Publicado: (2022)

Predictive models for mild cognitive impairment to Alzheimer’s disease conversion
por: Skolariki, Konstantina, et al.
Publicado: (2021)

Perspectives on mild cognitive impairment as a precursor of Alzheimer's disease
por: Fiorini, Rosamaria, et al.
Publicado: (2020)

On the Question of Sporadic or Atypical Bovine Spongiform Encephalopathy and Creutzfeldt-Jakob Disease
por: Brown, Paul, et al.
Publicado: (2006)

Repurposing cancer drugs to treat neurological diseases – Src inhibitors as examples
por: Liu, Da Zhi
Publicado: (2017)

Drug repurposing for neuroregeneration in multiple sclerosis
por: Küry, Patrick, et al.
Publicado: (2018)

Multiple sclerosis drug repurposing for neuroregeneration
por: Göttle, Peter, et al.
Publicado: (2023)

Repurposing niclosamide for the treatment of neurological disorders
por: Apolloni, Savina, et al.
Publicado: (2023)

What good is the reserve? A translational perspective for the managing of cognitive decline
por: Serra, Laura, et al.
Publicado: (2019)

Population measures of subjective cognitive decline: A means of advancing public health policy to address cognitive health
por: Olivari, Benjamin S., et al.
Publicado: (2021)

Considerations for the assessment of suicidal ideation and behavior in older adults with cognitive decline and dementia
por: Alphs, Larry, et al.
Publicado: (2016)

Alzheimer's disease in Down syndrome: An overlooked population for prevention trials
por: Strydom, André, et al.
Publicado: (2018)

Periodontitis and Cognitive Decline in Alzheimer’s Disease
por: Ide, Mark, et al.
Publicado: (2016)

Reversal of cognitive decline in Alzheimer's disease
por: Bredesen, Dale E., et al.
Publicado: (2016)

Cognitive Decline: Not Always Alzheimer’s Disease
por: Villalba, Noel Lorenzo, et al.
Publicado: (2018)

Perspective: Estrogen and the Risk of Cognitive Decline: A Missing Choline(rgic) Link?
por: Bortz, Jonathan, et al.
Publicado: (2021)

New approaches for prevention and treatment of Alzheimer's disease: a fascinating challenge
por: Piemontese, Luca
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_05sesdjldfhtnp45ithh2f13nq